Shares of Atlassian tumbled 8.1% to $68.38 on March 24 as the collaboration-software maker confronts likely removal from the Nasdaq-100 index in April, a consequence of a stock collapse that has erased more than half the company's value in three months. The threat triggers a painful cycle: index funds that track the Nasdaq-100 would be forced to dump shares, adding more selling pressure to a stock already near its 52-week low of $67.85.

  • The Index Trap: Forced Selling Begets More Selling. Under Nasdaq rules, a company that fails to maintain a weight of at least 0.10% for two consecutive month-ends — while ranking outside the top 100 by market cap — faces removal.

Atlassian's market cap has shriveled to roughly $19.8 billion , a fraction of the index's median constituent. When a stock is cut, the deletion triggers automatic selling by ETFs and passive funds , which can accelerate declines — exactly what shareholders fear most right now.

  • Revenue Is Growing, but Investors Don't Care. Quarterly revenue rose 23% to $1.59 billion, beating estimates, and adjusted earnings per share jumped to $1.22 versus expectations of $1.14. Yet Atlassian still posted a $47.7 million operating loss under standard accounting rules, inflated by $452.6 million in stock-based compensation — well over a third of revenue. When you pay employees heavily in shares while the stock craters, the math gets ugly.

  • AI Fear Is the Root Cause. Investors worry that new AI tools will displace Atlassian's core products by offering easier, customizable alternatives for project-tracking and team collaboration. Atlassian sells mostly to small and medium-sized businesses, making it more vulnerable to new competition. The company cut 1,600 jobs — 10% of its workforce — to fund AI investments , but that pivot is unproven.

  • Legal Clouds and a Leadership Shuffle Add Uncertainty. Pomerantz LLP is investigating whether Atlassian adequately disclosed risks related to growth deceleration. Meanwhile, a new CFO, James Chuong, formerly LinkedIn's finance chief, takes over March 30 — days before any index removal would take effect. Twenty-five of 33 analysts still rate TEAM a buy, with a consensus target of $206 , roughly 3x the current price. That gap between Wall Street optimism and market reality is either a screaming buy signal or a sign that the old thesis is broken.